ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In other words, BCR-ABL is required but not sufficient for the production of CML LSCs, which may necessitate further BCR-ABL copy number multiplication, subsequent mutations, and genomic instability [9].